专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2011102684A3 COMPOSITION CONTAINING PLACENTA EXTRACTS 审中-公开
标题翻译：含有特殊提取物的组合物
公开(公告)号：WO2011102684A3
公开(公告)日：2012-01-19
申请号：PCT/KR2011001110
申请日：2011-02-21
申请人： UNIV YEUNGNAM IACF , CHOI IN-HO , LEE DONG-MOK , LEE EUN-JU , LEE KI-HO , CHEON YONG-PIL , CHUN TAE-HOON
发明人： CHOI IN-HO , LEE DONG-MOK , LEE EUN-JU , LEE KI-HO , CHEON YONG-PIL , CHUN TAE-HOON
IPC分类号： A61K35/50 , A61P15/00 , A61P19/10 , C12N5/071
CPC分类号： A61K31/5685 , A61K31/565 , A61K31/568 , A61K35/50 , C12N5/0605
摘要： The present invention relates to a composition containing placenta extracts as active ingredients. More particularly, placenta extracts which are natural substances extracted from placentas of livestock exhibit effects that can replace steroids and reduce adverse effects of steroids, and therefore, can be valuably and widely used as contraceptives, anti-osteoporosis drugs, anti-anemic drugs, therapeutic agents for wasting diseases of muscular atrophy, agents for treating sexual dysfunction, therapeutic agents for wounds, adipocyte differentiation stimulating agents for improving meat quality of livestock, etc.
摘要翻译：本发明涉及含有胎盘提取物作为活性成分的组合物。更具体地说，作为从家畜胎盘中提取的天然物质的胎盘提取物具有能够代替类固醇并减少类固醇的不良反应的作用，因此可以作为避孕药，抗骨质疏松药物，抗贫血药物，治疗剂用于消除肌肉萎缩症的药剂，用于治疗性功能障碍的药剂，用于伤口的治疗剂，用于改善家畜肉质的脂肪细胞分化刺激剂等。

2. 发明申请

WO2009054697A2 OPENING AND CLOSING DEVICE FOR USE IN PORTABLE DEVICE HAVING TWO UNITS SLIDING EACH OTHER 审中-公开
标题翻译：开启和关闭装置，用于便携式装置，每个装置有两个滑动装置
公开(公告)号：WO2009054697A2
公开(公告)日：2009-04-30
申请号：PCT/KR2008/006297
申请日：2008-10-24
申请人： AMPHENOL PHOENIX CO., LTD. , KA, Sung hyun , LEE, Ki ho
发明人： KA, Sung hyun , LEE, Ki ho
IPC分类号： H04B1/38
CPC分类号： H04M1/0237
摘要： Disclosed is an opening and closing device so that a resilient unit one end of which is rotatably connected to a fixed section fixed to the first unit and the opposite end of which is rotatably connected to a movable section fixed to the second unit, whereby the opening and closing device can be made thinner. A opening and closing device for use in a portable device which slidably opens and closes a second unit with respect to a first unit comprises: a fixed section fixed to the first unit; a movable section fixed to the second unit; movable rails fixed to the movable section and movable along the fixed section; and a resilient member opposite ends of which are rotatably connected to the fixed section and the movable section to provide a resilient force to the second unit.
摘要翻译：公开了一种开闭装置，使得弹性单元的一端可旋转地连接到固定到第一单元的固定部分，并且其相对端可旋转地连接到固定的可移动部分到第二单元，由此能够使开闭装置更薄。一种用于便携式装置中的开闭装置，该便携式装置相对于第一单元可滑动地打开和关闭第二单元，该开闭装置包括：固定到第一单元的固定部分; 固定到第二单元的可移动部分; 固定在所述可动部上并能够沿着所述固定部移动的可动导轨; 以及弹性构件，其相对端部可旋转地连接到固定部分和可移动部分以向第二单元提供弹性力。

3. 发明申请

WO2008140198A1 NOVEL CARBAMOYLOXY ARYLALKANOYL ARYLPIPERAZINE COMPOUND, PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND AND METHOD FOR TREATING PAIN, ANXIETY AND DEPRESSION BY ADMINISTERING THE COMPOUND 审中-公开
标题翻译：新型卡巴酰氧基亚氨基亚氨基哌啶化合物，包含该化合物的药物组合物和通过施用化合物治疗疼痛，不适和呕吐的方法
公开(公告)号：WO2008140198A1
公开(公告)日：2008-11-20
申请号：PCT/KR2008/002470
申请日：2008-04-30
申请人： SK HOLDINGS CO., LTD. , KWAK, Byong Sung , MOON, Hong Sik , YI, Han-Ju , KANG, Young Soon , IM, Dae Joong , CHAE, Eun Hee , CHAE, Sang Mi , LEE, Ki Ho
发明人： KWAK, Byong Sung , MOON, Hong Sik , YI, Han-Ju , KANG, Young Soon , IM, Dae Joong , CHAE, Eun Hee , CHAE, Sang Mi , LEE, Ki Ho
IPC分类号： C07D413/06 , C07D211/58 , C07D471/02 , C07D401/12 , A61P25/24
CPC分类号： C07D239/42 , C07D213/74 , C07D241/04 , C07D241/44 , C07D265/18 , C07D265/36 , C07D295/033 , C07D307/54 , C07D317/58 , C07D317/66 , C07D319/18
摘要： There is provided a novel carbamoyloxy arylalkanoyl arylpiperazine derivative compound having abundant racemic or enantiomeric characteristics, represented by the Formula 1, and pharmaceutically available salts or hydrates thereof. Also, there are provided a pharmaceutical composition for treating pain, anxiety or depression including an effective amount of the compound, and a method for treating pain, anxiety or depression in mammals by administering an effective amount of the compound to the mammals in need of treatment thereof.
摘要翻译：提供了具有由式1表示的大量外消旋或对映体特征的新型氨基甲酰氧基芳基烷酰基芳基哌嗪衍生物化合物及其药学上可用的盐或水合物。此外，提供了一种用于治疗疼痛，焦虑或抑郁的药物组合物，包括有效量的化合物，以及通过向需要治疗的哺乳动物施用有效量的化合物来治疗哺乳动物的疼痛，焦虑或抑郁的方法它们。

4. 发明申请

WO2006049404A1 SPHINGOSINE KINASE ACTIVATOR AND SKIN DISEASE TREATING AGENT COMPRISING THE SAME 审中-公开
标题翻译：丝氨酸激酶激活剂和包含其的皮肤病治疗药物
公开(公告)号：WO2006049404A1
公开(公告)日：2006-05-11
申请号：PCT/KR2005/003586
申请日：2005-10-27
申请人： NEOPHARM CO., LTD. , PARK, Byeong-Deog , YOUM, Jong-Kyung , GWAK, Hyung-Sub , KWON, Mi-Jong , LEE, Yong-Moon , KIM, Yoo-Hun , KIM, Hwan-Mook , PARK, Song-Kyu , LEE, Ki-Ho , LEE, Chang-Woo , LEE, Myong-Lyoll
发明人： PARK, Byeong-Deog , YOUM, Jong-Kyung , GWAK, Hyung-Sub , KWON, Mi-Jong , LEE, Yong-Moon , KIM, Yoo-Hun , KIM, Hwan-Mook , PARK, Song-Kyu , LEE, Ki-Ho , LEE, Chang-Woo , LEE, Myong-Lyoll
IPC分类号： A61K31/164
CPC分类号： C07C235/08 , A61K8/68 , A61Q19/08 , C07C235/74
摘要： Disclosed is a non-natural ceramide compound effective for a sphingosine kinase activator, and thus useful for a skin disease treating agent. The sphingosine kinase activator enhances production of sphingosine-1-phosphate to show various physiological activities provided by sphingosine-1-phosphate. The physiological activities include the effects of: controlling multiplication and differentiation of keratinocytes, multiplication of fibroblasts and collagen synthesis, resulting in treatment of wounds, recovery of damaged skin functions in atopic dermatitis and psoriasis; inhibiting wrinkles and skin irritation caused by ultraviolet rays, followed by improvement of wrinkles and inhibition of skin aging; and reducing skin atrophy, which is a typical side effect of local application steroids. Therefore, the sphingosine kinase activator is useful for a skin disease treating agent for treating skin wounds, wrinkles, atopic dermatitis, eczema, psoriasis, or skin atrophy caused by side effects of local application steroids.
摘要翻译：公开了对鞘氨醇激酶活化剂有效的非天然神经酰胺化合物，因此可用于皮肤疾病治疗剂。鞘氨醇激酶激活剂增强了鞘氨醇-1-磷酸的产生，以显示由鞘氨醇-1-磷酸提供的各种生理活性。生理活动包括：控制角质形成细胞的增殖和分化，成纤维细胞的增殖和胶原合成，导致伤口的治疗，恢复特应性皮炎和牛皮癣损伤的皮肤功能; 抑制由紫外线引起的皱纹和皮肤刺激，随后改善皱纹和抑制皮肤老化; 并减少皮肤萎缩，这是局部应用类固醇的典型副作用。因此，鞘氨醇激酶激活剂可用于皮肤疾病治疗剂，用于治疗由局部应用类固醇的副作用引起的皮肤伤口，皱纹，特应性皮炎，湿疹，牛皮癣或皮肤萎缩。

5. 发明申请

WO2012141424A3 METHOD AND APPARATUS FOR CONTROLLING FEMTOCELL CONNECTION 审中-公开
标题翻译：用于控制FEMTOCELL连接的方法和装置
公开(公告)号：WO2012141424A3
公开(公告)日：2013-01-10
申请号：PCT/KR2012001087
申请日：2012-02-14
申请人： KT CORP , LEE KI-HO , LEE YONG-GYOO , JI YUNG-HA
发明人： LEE KI-HO , LEE YONG-GYOO , JI YUNG-HA
IPC分类号： H04W36/04 , H04W36/30 , H04W36/38 , H04W48/02
CPC分类号： H04W36/0061 , H04W36/0083 , H04W48/02 , H04W84/045
摘要： A second femtocell base station generates a handover permission message with regard to a plurality of neighboring femtocell base stations when the second femtocell base station has a closed subscriber group (CSG) identifier that is different from a CSG identifier of a first femtocell base station, so that a user equipment can control a handover, wherein the second femtocell base station neighbors a first femtocell base station that is connected to the user equipment. The handover permission message that is generated is transmitted to and saved in a gateway, which is connected to the second femtocell base station, and a handover between femtocells is controlled by selecting a resource to be provided to the terminal and connecting to the user equipment, when the handover with regard to the terminal is requested from the gateway.
摘要翻译：当第二毫微微小区基站具有与第一毫微微小区基站的CSG标识符不同的封闭用户组（CSG）标识符时，第二毫微微小区基站关于多个相邻毫微微小区基站生成切换许可消息，因此用户设备可以控制切换，其中第二毫微微小区基站邻近与用户设备连接的第一毫微微小区基站。生成的切换允许消息被发送到并保存在连接到第二毫微微小区基站的网关中，并且通过选择要提供给终端并连接到用户设备的资源来控制毫微微小区之间的切换，当从网关请求关于终端的切换时。

6. 发明申请

WO2012053768A3 ARYLOXYPHENOXYACETYL-BASED COMPOUND HAVING HIF-1 INHIBITION ACTIVITY, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT 审中-公开
标题翻译：具有HIF-1抑制活性的含有芳基氧基乙酰基的化合物，其制备方法和含有其作为活性成分的药物组合物
公开(公告)号：WO2012053768A3
公开(公告)日：2012-06-21
申请号：PCT/KR2011007589
申请日：2011-10-12
申请人： KOREA RES INST OF BIOSCIENCE , UNIV DONGGUK IND ACAD COOP , WON MI-SUN , KIM HWAN-MOOK , LEE KYEONG , PARK SONG-KYU , LEE KI-HO , LEE CHANG-WOO , LEE JUNG-JOON , CHUNG KYUNG-SOOK , KIM BO-KYUNG , JIN YING-LAN
发明人： WON MI-SUN , KIM HWAN-MOOK , LEE KYEONG , PARK SONG-KYU , LEE KI-HO , LEE CHANG-WOO , LEE JUNG-JOON , CHUNG KYUNG-SOOK , KIM BO-KYUNG , JIN YING-LAN
IPC分类号： C07C235/38 , A61K31/167 , A61P35/00 , C07C231/02
CPC分类号： C07C235/24 , C07C2603/74
摘要： Disclosed are a compound inhibitory of HIF-1 activity, a method for preparing the same, and a pharmaceutical composition comprising the same as an active ingredient. The compound has anticancer activity which is attributable to its inhibitory activity against HIF-1, but not to non-selective cellular toxicity. Thus, having inhibitory activity against HIF-1, the compound or a pharmaceutically acceptable salt thereof can be used as an ingredient in an anticancer agent for various cancers including large intestine cancer, hepatic cancer, stomach cancer and breast cancer. Further, the compound or a pharmaceutically acceptable salt thereof is applicable to the treatment of diabetic retinopathy or arthritis which is aggravated upon the activation of VEGFA by HIF-1.
摘要翻译：公开了HIF-1活性的化合物抑制剂，其制备方法，以及含有该化合物作为活性成分的药物组合物。该化合物具有抗癌活性，其归因于其对HIF-1的抑制活性，但不归因于非选择性细胞毒性。因此，对于HIF-1具有抑制活性，该化合物或其药学上可接受的盐可用作各种癌症，包括大肠癌，肝癌，胃癌和乳腺癌的抗癌剂中的成分。此外，化合物或其药学上可接受的盐适用于治疗通过HIF-1激活VEGFA时加重的糖尿病性视网膜病变或关节炎。

7. 发明申请

WO2012053768A2 ARYLOXYPHENOXYACETYL-BASED COMPOUND HAVING HIF-1 INHIBITION ACTIVITY, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT 审中-公开
标题翻译：具有HIF-1抑制活性的芳氧基苯氧基乙酰基化合物，其制备方法以及含有该化合物作为活性成分的药物组合物
公开(公告)号：WO2012053768A2
公开(公告)日：2012-04-26
申请号：PCT/KR2011/007589
申请日：2011-10-12
申请人： Korea Research Institute of Bioscience and Biotechnology , Dongguk University Industry-Academic Cooperation Foundation , WON, Mi-Sun , KIM, Hwan-Mook , LEE, Kyeong , PARK, Song-Kyu , LEE, Ki-Ho , LEE, Chang-Woo , LEE, Jung-Joon , CHUNG, Kyung-Sook , KIM, Bo-Kyung , JIN, Ying-Lan
发明人： WON, Mi-Sun , KIM, Hwan-Mook , LEE, Kyeong , PARK, Song-Kyu , LEE, Ki-Ho , LEE, Chang-Woo , LEE, Jung-Joon , CHUNG, Kyung-Sook , KIM, Bo-Kyung , JIN, Ying-Lan
IPC分类号： C07C235/38 , C07C231/02 , A61K31/167 , A61P35/00
CPC分类号： C07C235/24 , C07C2603/74
摘要： Disclosed are a compound inhibitory of HIF-1 activity, a method for preparing the same, and a pharmaceutical composition comprising the same as an active ingredient. The compound has anticancer activity which is attributable to its inhibitory activity against HIF-1, but not to non-selective cellular toxicity. Thus, having inhibitory activity against HIF-1, the compound or a pharmaceutically acceptable salt thereof can be used as an ingredient in an anticancer agent for various cancers including large intestine cancer, hepatic cancer, stomach cancer and breast cancer. Further, the compound or a pharmaceutically acceptable salt thereof is applicable to the treatment of diabetic retinopathy or arthritis which is aggravated upon the activation of VEGFA by HIF-1.
摘要翻译：公开了抑制HIF-1活性的化合物，其制备方法以及包含其作为活性成分的药物组合物。该化合物具有抗Hcy-1抑制活性的抗癌活性，但不具有非选择性细胞毒性。因此，对HIF-1具有抑制活性的化合物或其药学上可接受的盐可用作包括大肠癌，肝癌，胃癌和乳腺癌的各种癌症的抗癌剂的成分。此外，该化合物或其药学上可接受的盐适用于治疗由HIF-1激活VEGFA而加重的糖尿病性视网膜病或关节炎。

8. 发明申请

WO2011059199A3 RELAY STATION DATA TRANSMISSION METHOD 审中-公开
标题翻译：继电器数据传输方法
公开(公告)号：WO2011059199A3
公开(公告)日：2011-11-03
申请号：PCT/KR2010007655
申请日：2010-11-02
申请人： LG ELECTRONICS INC , UNIV SOONGSIL RES CONSORTIUM , KIM HAK SEONG , SHIN YO AN , LEE KI HO , KIM KI JUN , KIM SAN HAE
发明人： KIM HAK SEONG , SHIN YO AN , LEE KI HO , KIM KI JUN , KIM SAN HAE
IPC分类号： H04W72/12
CPC分类号： H04W72/1231 , H04W72/1278 , H04W84/047
摘要： Provided is a relay station uplink control signal transmission method. The method comprises the steps of: setting a UL relay station zone where a relay station transmits a signal to a base station, within a frame; setting a resource unit comprising a plurality of symbols and a plurality of subcarriers, for allocating an uplink control signal to a subframe of the UL relay station zone; and transmitting the uplink control signal via the resource unit. In this method, when the subframe comprises the transition time necessary for signal send and receive switching at the relay station, the uplink control signal is transmitted on a symbol which remains after excluding the plurality of symbols constituting the resource unit comprising the transition time.
摘要翻译：提供了一种中继站上行控制信号传输方法。该方法包括以下步骤：在帧内设置中继站向基站发送信号的UL中继站区域; 设置包括多个符号和多个子载波的资源单元，用于将上行链路控制信号分配给所述UL中继站区域的子帧; 以及经由所述资源单元发送所述上行链路控制信号。在该方法中，当子帧包括在中继站的信号发送和接收切换所需的转换时间时，上行链路控制信号是在排除构成包括转换时间的资源单元的多个符号之后保留的符号上发送的。

9. 发明申请

WO2010126249A2 FEMTOCELL ACCESS POINT FOR AUTOMATICALLY SETTING AND REGISTERING LOCATION-RELATED UNIQUE IDENTIFICATION INFORMATION, AND METHOD FOR SAME 审中-公开
标题翻译：用于自动设置和注册与位置相关的唯一标识信息的FEMTOCELL接入点及其相关方法
公开(公告)号：WO2010126249A2
公开(公告)日：2010-11-04
申请号：PCT/KR2010002509
申请日：2010-04-21
申请人： KT CORP , LEE KI-HO , LEE HEE-JUN , PARK JOONG-WAN , PARK JONG-HO
发明人： LEE KI-HO , LEE HEE-JUN , PARK JOONG-WAN , PARK JONG-HO
IPC分类号： H04W16/18 , H04B7/26
CPC分类号： H04W24/02 , H04W8/26 , H04W28/06 , H04W48/16 , H04W84/045
摘要： The present invention relates to a femtocell access point to be located in the coverage of a macrocell to automatically set and register location-related unique identification information thereof, considering location-related unique identification information of the macrocell. The present invention also relates to a method for same. The femtocell access point to be located in the coverage of a macrocell according to the present invention comprises: a receiving unit which receives a broadcast signal from the macrocell; an extraction unit which extracts location-related unique identification information of the macrocell from the received broadcast signal; and a setting unit which sets the extracted location-related unique identification information as location-related unique identification information of a femtocell. The femtocell access point sets location-related unique identification information identical to that of the macrocell, and transmits a broadcast signal to a mobile terminal, to thereby prevent frequent location registration of the mobile terminal and enabling the mobile terminal to receive the same paging message in the macrocell and the femtocell.
摘要翻译：本发明涉及考虑宏小区的位置相关的唯一识别信息，位于宏小区的覆盖范围内的毫微微小区接入点，以自动设置和注册位置相关的唯一识别信息。本发明还涉及其相应的方法。根据本发明的位于宏小区的覆盖范围内的毫微微小区接入点包括：接收单元，其从宏小区接收广播信号; 提取单元，从接收到的广播信号中提取宏小区的位置相关唯一识别信息; 以及设置单元，其将所提取的位置相关的唯一标识信息设置为毫微微小区的位置相关唯一标识信息。毫微微小区接入点设置与宏小区的位置相关的唯一识别信息，并将广播信号发送到移动终端，从而防止移动终端的频繁位置登记，并使移动终端能够接收相同的寻呼消息宏小区和毫微微小区。

10. 发明申请

WO2010123243A2 COMPOSITION CONTAINING A TESTIS EXTRACT FOR TREATING OR PREVENTING DISEASES 审中-公开
标题翻译：包含用于治疗或预防疾病的检测提取物的组合物
公开(公告)号：WO2010123243A2
公开(公告)日：2010-10-28
申请号：PCT/KR2010002438
申请日：2010-04-20
申请人： UNIV YEUNGNAM IACF , CHOI IN-HO , LEE DONG-MOK , LEE EUN-JU , LEE KI-HO , CHEON YONG-PIL , CHUN TAE-HOON
发明人： CHOI IN-HO , LEE DONG-MOK , LEE EUN-JU , LEE KI-HO , CHEON YONG-PIL , CHUN TAE-HOON
IPC分类号： A61K35/48 , A61P15/00 , A61P19/00 , A61P21/00 , A61P37/00
CPC分类号： A61K35/48
摘要： The present invention relates to a composition containing a testis extract for treating or preventing diseases. More particularly, a testis extract, which is a natural substance obtained by separating sex hormones containing anabolic steroids from the testes of livestock, is used as contraceptives, drugs for treating osteoporosis, an antianemic agent, a therapeutic agent for wasting diseases of muscular atrophy, an agent for treating sexual dysfunction, a therapeutic agent for immune diseases, a therapeutic agent for wounds, etc., thereby replacing conventional steroids, reducing the side effects of steroids and treating a wide range of human diseases.
摘要翻译：本发明涉及含有用于治疗或预防疾病的睾丸提取物的组合物。更具体地说，作为通过从家畜睾丸中分离含有合成代谢类固醇的性激素获得的天然物质的睾丸提取物被用作避孕药，用于治疗骨质疏松症的药物，抗增援剂，用于消除肌肉萎缩疾病的治疗剂，用于治疗性功能障碍的药物，免疫疾病的治疗剂，伤口的治疗剂等，从而代替常规类固醇，减少类固醇的副作用并治疗广泛的人类疾病。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式